Diamyd Medical AB (publ) Cash Flow Reinvestment Rate
Diamyd Medical AB (publ) cash flow reinvestment rate. Diamyd Medical AB (publ) (DMYD-B) has a Cash Flow Reinvestment Rate of 2978.57x as of November 2021, reinvesting Skr62.55 Million (capex Skr42.55 Million plus investments Skr-20.00 Million) from operating cash flow of Skr21.00K. See Diamyd Medical AB (publ) leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Diamyd Medical AB (publ) (2010–2020)
Cash flow reinvestment rate of Diamyd Medical AB (publ) from 2010 to 2020. Historical reinvestment intensity for Diamyd Medical AB (publ) across 2 annual periods. Explore DMYD-B cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Diamyd Medical AB (publ) Cash Flow Reinvestment Rate by Year (2010–2020)
Diamyd Medical AB (publ) cash flow reinvestment rate by year from 2010 to 2020. Year-by-year capital reinvestment analysis for Diamyd Medical AB (publ). For the full cash flow conversion analysis, see cash flow conversion of Diamyd Medical AB (publ).
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.52x | Skr8.78 Million | Skr16.88 Million | Skr1.98 Million | ▲ +16674.5% |
| 2010 | 0.00x | Skr700.00K | Skr225.77 Million | Skr700.00K | — |